Chinese Regulators Clear Thermo Fisher Acquisition of Life Tech | GenomeWeb

NEW YORK (GenomeWeb News) – China's Ministry of Commerce has approved Thermo Fisher's $15.8 billion acquisition of Life Technologies, pending the divestiture of Thermo Fisher's cell culture business and several other conditions.

In addition to the sale of the cell culture business, the Ministry of Commerce has asked Thermo Fisher to sell its stake in Lanzhou National Hyclone Bio-engineering Co., to divest its gene modulation business, and to reduce the price of its SSP kits and SDS-PAGE protein standards in the Chinese market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.